Inaba Toshiro | Department Of Cardiology The Cardiovascular Institute

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-664 Sirolimus-Eluting versus Bare Metal Stents in Acute Coronary Syndrome : From a Prospective Cohort Study of Shinken Database 2004-5(Coronary revascularization, PCI(25)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese
PJ-365 Predictor of Major Adverse Cardiac Event in Acute Coronary Syndrome : The Shinken Database 2004-5(Preventive medicine/Epidemiology/Education(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
PJ-142 Angioscopic and Histopathological Characterization of Heterogeneous Patterns of Restenosis After Sirolimus-Eluting Stent Implantation : Insights into Potential "Thromborestenosis" Phenomenon(Intravascular endoscopy/Intravascular ultrasound(05)(I),P
PE-171 Comparison between Stent Implantation for Right and Left Aortoostial Coronary Artery Diseases : Right Ostium is More Susceptible to Restenosis(Coronary revascularization, PCI(09)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of th
PE-050 Clinical Outcome and Predictor of Target Vessel Revascularization After Simple Stenting of Sirolimus-Eluting Stents for Left Main Coronary Artery Bifurcation(Coronary revascularization, PCI(07)(IHD),Poster Session(English),The 72nd Annual Scientifi
PE-002 How should we Treat for Ischemic Heart Disease in Dialysis Patients : PCI or CABG?(Angina pectoris, basic/clinical(03)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OJ-180 The Relationship between Residual Plaque Burden and Neointimal Hyperplasia for Chronic Total Occlusion : Insight from Intravascular Ultrasound Findings(Intravascular endoscopy / Intravascular ultrasound(02)(I),Oral Presentation (Japanese),The 72nd
PE-462 Impact of Albuminuria on Coronary Artery Disease(PE078,Angina Pectoris (Clinical) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
PE-281 Impact of Drug-Eluting Stent for Coronary Artery Disease on Mortality and Morbidity(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-278 Predictors of Major Adverse Cardiac Event in Drug-Eluting Stent Era(PE047,Coronary Revascularization, PCI (DES) 4 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-039 Prevalence and Prognosis of Coronary Artery Disease in Japanese Patients : Shinken Database 2004-6(PE007,Preventive Medicine/Epidemiology/Education 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Societ
OJ-030 Distribution and Predictive Value of Renal Insufficiency in Coronary Artery Disease(OJ05,Peripheral Circulation/Vascular Disease (Therapy) 1 (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OE-208 Arterial Stiffness and Long-term Prognosis in Patients with Coronary Artery Disease(OE36,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
Clinical outcomes after percutaneous peripheral intervention for chronic total occlusion of superficial femoral arteries : Comparison between self-expandable nitinol stent and stainless steel stent
PE-378 Serial Angiographic and Intravascular Ultrasound Follow-up Analysis of Late Restenosis and Non-restenosis Patients after Sirolimus-eluting Stent Implantaion(PE064,Coronary Revascularization, PCI (DES) 6 (IHD),Poster Session (English),The 73rd Annua
PE-143 Insight Into The Predictors Of Paclitaxel-eluting Stent Restenosis(PE024,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OE-395 Intravascular Ultrasonic, Angioscopic and Histopathological Characterization of Heterogeneous Patterns of Restenosis after Sirolimus-Eluting Stent Implantation : Insights into Potential "Thromborestenosis" Phenomenon(OE67,Coronary Revascularization
PE-356 Discrimination of Responders to Cardiac Resynchronization Therapy by CardioGRAF ECG-gated SPECT(Nuclear cardiology-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
OE-002 Impact of Statin Treatment for Ischemic Heart Disease on Mortality and Morbidity : Shinken Database 2004-6(OE01,Cardiovascular Pharmacology (Clinical) (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation So
Initial and Programmed Combination Therapy With Oral Drugs for Severe Idiopathic Pulmonary Arterial Hypertension
Novel Risk Scoring System With Preoperative Objective Parameters Gives a Good Prediction of 1-Year Mortality in Patients With a Left Ventricular Assist Device
A case of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device
Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient
Trend of Clinical Outcome and Surrogate Markers During Titration of β-Blocker in Heart Failure Patients With Reduced Ejection Fraction : – Relevance of Achieved Heart Rate and β-Blocker Dose –
Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
Rapidly Progressive Cardiac Allograft Vasculopathy in Early Onset Regressed With Everolimus Treatment in an Adult Cardiac Recipient
Correction of Hyponatremia by Tolvaptan Before Left Ventricular Assist Device Implantation
Early decision for a left ventricular assist device implantation is necessary for patients with modifier A
A Case of Pancreatic Cancer After Heart Transplantation
Combination Evaluation of Preoperative Risk Indices Predicts Requirement of Biventricular Assist Device
Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation
Everolimus-Incorporated Immunosuppressant Strategy Improves Renal Dysfunction While Maintaining Low Rejection Rates After Heart Transplantation in Japanese Patients
A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality
Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
Tolvaptan Can Improve Clinical Course in Responders:Validation Analysis for the Definition of Responsiveness by Urine Volume
How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
Trend of Clinical Outcome and Surrogate Markers During Titration of β-Bloeker in Heart Failure Patients With Reduced Ejection Fraction : Relevance of Achieved Heart Rate and β-Blocker Dose
Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients : Association Between Non-Responders and Chronic Kidney Disease
Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure:– Its Relevance to Poor Prognosis and Reversal by Surgical Treatment –
Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure
Recipients With Shorter Cardiopulmonary Bypass Time Achieve Improvement of Parasympathetic Reinnervation Within 6 Months After Heart Transplantation

もっと見る

スポンサーリンク